Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing.
Hill TF, Narvekar P, Asher GD, Edelstein JN, Camp ND, Grimm A, Thomas KR, Leiken MD, Molloy KM, Cook PJ, Arlauckas SP, Morgan RA, Tasian SK, Rawlings DJ, James RG.
Hill TF, et al. Among authors: narvekar p.
Mol Ther. 2024 Aug 7;32(8):2676-2691. doi: 10.1016/j.ymthe.2024.06.004. Epub 2024 Jul 2.
Mol Ther. 2024.
PMID: 38959896